Episodes

  • Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

    Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market
    Sep 10 2026
    In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
    Show More Show Less
    4 mins
  • Pharma Pulse: MFN Expansion, GoodRx's Family Plan, CSafe's Reusable Cover

    Pharma Pulse: MFN Expansion, GoodRx's Family Plan, CSafe's Reusable Cover
    Sep 4 2026
    In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx extends savings to the whole household, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
    Show More Show Less
    4 mins
  • Pharma Pulse: Medicaid Deals, GLP-1 Pullback, McKesson's Buy

    Pharma Pulse: Medicaid Deals, GLP-1 Pullback, McKesson's Buy
    Aug 27 2026
    In this week's Pharma Pulse, new Medicaid pricing deals are rumored, employer GLP-1 pullback, and McKesson's $2.25B oncology buy.
    Show More Show Less
    3 mins
  • Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine

    Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine
    Aug 20 2026
    In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization platform into medical affairs and market research, Moderna and Merck's personalized mRNA cancer vaccine clears a landmark Phase 3 trial, and IAG Cargo expands its pharma cold chain network into Kuala Lumpur.
    Show More Show Less
    4 mins
  • Pharma Pulse: Retatrutide's Black Market Problem, BMS's Houston Bet, FDA's DSCSA Assessment

    Pharma Pulse: Retatrutide's Black Market Problem, BMS's Houston Bet, FDA's DSCSA Assessment
    Aug 13 2026
    In this week's Pharma Pulse, Eli Lilly sues companies over black-market retatrutide sales, Bristol Myers Squibb commits $2.3 billion to a new Houston manufacturing campus, and FDA opens an assessment of small dispensers' DSCSA tracing capabilities.
    Show More Show Less
    5 mins
  • Pharma Pulse: AstraZeneca-BMS Chatter and Drone Delivery In the Last Mile

    Pharma Pulse: AstraZeneca-BMS Chatter and Drone Delivery In the Last Mile
    Aug 6 2026
    In this week's Pharma Pulse, a senior source denies AstraZeneca and Bristol Myers Squibb are in merger talks, Cleveland Clinic and Arrive AI push drone delivery toward pharma's last mile, Kenco's AI rollout signals where 3PL is headed, and TailorMed and WeInfuse team up to expand infusion access.
    Show More Show Less
    4 mins
  • Pharma Pulse: Infinitus' AI Hub Play, EVERSANA's Cell Therapy Partnership, Cold Chain Deals

    Pharma Pulse: Infinitus' AI Hub Play, EVERSANA's Cell Therapy Partnership, Cold Chain Deals
    Jul 30 2026
    In this week's Pharma Pulse, Infinitus launches an AI-first hub model, EVERSANA is tapped to commercialize Innovacell's regenerative cell therapy in the US, Peli BioThermal and PAXAFE pair packaging with predictive cold chain intelligence, and Ember LifeSciences strikes a distribution alliance with Japan's top pharma wholesaler.
    Show More Show Less
    5 mins
  • Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs

    Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs
    Jul 23 2026
    In this week's Pharma Pulse, Cardinal Health expands its at-Home Solutions business with two acquisitions, President Trump lays out a phased tariff schedule for generic drugs, and Novo Nordisk sues Eli Lilly over GLP-1 advertising claims.
    Show More Show Less
    4 mins